Search by Drug Name or NDC
NDC 68047-0753-30 Butalbital and Acetaminophen 325; 25 mg/1; mg/1 Details
Butalbital and Acetaminophen 325; 25 mg/1; mg/1
Butalbital and Acetaminophen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL.
Product Information
NDC | 68047-0753 |
---|---|
Product ID | 68047-753_0771bcff-6b38-c003-e063-6294a90a32a8 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Butalbital and Acetaminophen |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | butalbital and acetaminophen |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 325; 25 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | ACETAMINOPHEN; BUTALBITAL |
Labeler Name | Larken Laboratories, Inc. |
Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS] |
DEA Schedule | CIII |
Marketing Category | ANDA |
Application Number | ANDA203484 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68047-0753-30 (68047075330)
NDC Package Code | 68047-753-30 |
---|---|
Billing NDC | 68047075330 |
Package | 30 TABLET in 1 BOTTLE (68047-753-30) |
Marketing Start Date | 2022-07-18 |
NDC Exclude Flag | N |
Pricing Information | N/A |